Hyperinflation system is a medical devices used for breathing assistance. Hyperinflation of lung is generally used for secretion removal and to improve lung compliance.
Hyperinflation system is a medical devices used for breathing assistance. Hyperinflation of lung is generally used for secretion removal and to improve lung compliance. Chance of lung atelectasis occurrence increases in anaesthetized patient on 100% oxygen ventilation via hyperinflation system hence, oxygenated air or only air is preferred in hyperinflation system. Hyperinflation system comes with oxygen reservoirs (inflated O2 bags, corrugated tubing) and safety components (integrated pressure manometer, filters, pop-off valves and peep valves).
Hyperinflation system is mainly used for providing the infants with oxygen support in preterm births, emergency cases, hypoxia, and other conditions such as Asthma, Chronic obstructive pulmonary disease (COPD), etc. “Decreased lung capacity, decreased alveolar capacity, narrowing of airways, non-developed lungs (in case of preterm births) are some of the conditions where hyperinflation system is used to offer enhanced patient care and treatment. Prevalence of the chronic obstructive pulmonary disease (COPD) among the geriatric population has significantly contributed towards growth of the global hyperinflation system market” states Fact.MR
Request a Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=981
Increasing Geriatric Population May Trigger Market Uptake
Increasing worldwide aging population coupled with increasing prevalence of chronic obstructive pulmonary disease is attributed to global hyperinflation system market growth. Increasing awareness in middle and low income countries about COPD will further drive hyperinflation system market. Increasing prevalence of preterm births globally can further drive hyperinflation system market. In the emergency cases in hospitals, growing need for breathing assistance and hyperinflation continues to persist for delivering oxygenated air, removing secretions in the lungs, increase the lung capacity, and resulting in improved lung compliance in term driving hyperinflation system market. In addition, smoking has continued to remain a major cause of developing COPD among individuals.
Nearly 73% deaths occur due to COPD and increase in the tobacco smoking, which is expected to fuel the global hyperinflation system market. “Affordability of hyperinflation system devices has further contributed towards growth of the global hyperinflation system market. Hyperinflation system operates manually by squeezing air bag to infuse air into the lungs and when bag released air from lungs comes out which makes measuring of air pressure difficult even when manometer is attached, due to tedious process it acts as restraint in hyperinflation system market,” notes Fact.MR.
Request TOC At - https://www.factmr.com/report/981/hyperinflation-system-market
North America and Europe To Offer Promising Growth Opportunities
Hyperinflation system market is mainly dominated by North America attributed to the increasing number of COPD cases globally. Europe is also expected to account for a lucrative share in hyperinflation global market. However, the Asia-Pacific market is expected to emerge a as one of the leading hyperinflation system market over the coming years attributed to developing economies such as India and China. With vast population residing with increasing geriatric population in countries like in India and China Asia-Pacific hyperinflation system market is expected to grow significantly. The Middle East and Africa is expected to remain the least lucrative hyperinflation system market attributed to low adoption of treatment.
Some of the global key players operating in hyperinflation system market are Bay Medical, Smiths Medical, Mercury Medical, Westmed, Inc., Solutions in Critical Care, Teleflex Medical, Inc., Becton Dickinson & Co, and Others.
Explore Fact.MR’s Lucid Healthcare Coverage
Drug Discovery Services Market – Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services
Fluid Management Market – The rise in incidences of End Stage Renal Disease (ESRD) has pushed up demand for dialysis products, thus augmenting the global fluid management market. The market is poised to be leveraged moderately at a CAGR of 5.3% during the forecast period (2020-2025).
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates